Mumbai, Feb. 22 -- Senn Chemicals AG, a Swiss-based CDMO specializing in peptides. It develops and manufactures, Peptides and peptides based applications for its global customers, providing contract research, development, and manufacturing services. Its revenue for CY23 was CHF 26.9 million and it had estimated sales of CHF 19.6 million in the calendar year (CY) 2024.

The acquisition brings Senn's expertise in liquid-phase peptide synthesis (LPPS) and solid-phase peptide synthesis (SPPS), along with a strong CDMO business and established customer relationship, including innovators and brand owners across Pharma, Cosmetics, Amino Acid Derivatives (AAD) & theragnostic segments.

This acquisition enables Granules' acquiring capabilities int...